SCN8A self-limited infantile epilepsy: Does epilepsy resolve?
Journal Title
Epilepsia
Publication Type
Jun 7 epub ahead of print
Abstract
SCN8A variants cause a spectrum of epilepsy phenotypes ranging from self-limited infantile epilepsy (SeLIE) to developmental and epileptic encephalopathy. SeLIE is an infantile onset focal epilepsy, occurring in developmentally normal infants, which often resolves by 3 years. Our aim was to ascertain when epilepsy resolves in SCN8A-SeLIE. We identified unpublished individuals with SCN8A-SeLIE and performed detailed phenotyping. Literature was searched for published SCN8A-SeLIE cases. Nine unpublished individuals from four families were identified (age at study = 3.5-66 years). Six had their last seizure after 3 years (range = 4-21 years); although drug-responsive and despite multiple weaning attempts (1-5), five of six remain on antiseizure medications (carbamazepine, n = 3; lamotrigine, n = 2). We identified 29 published individuals with SCN8A-SeLIE who had data on seizure progression. Of the 22 individuals aged at least 10 years, reported here or in the literature, nine of 22 (41%) had seizure offset prior to 3 years, five of 22 (23%) had seizure offset between 3 and 10 years, and eight of 22 (36%) had seizures after 10 years. Our data highlight that more than half of individuals with SCN8A-SeLIE continue to have seizures into late childhood. In contrast to SeLIE due to other etiologies, many individuals have a more persistent, albeit drug-responsive, form of epilepsy.
Publisher
Wiley
Keywords
Scn8a; SeLIE; focal epilepsy; genetic epilepsy; seizure outcome
Research Division(s)
Population Health And Immunity
PubMed ID
38845412
Open Access at Publisher's Site
https://doi.org/10.1111/epi.18016
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-06-24 11:30:03
Last Modified: 2024-06-24 11:34:39
An error has occurred. This application may no longer respond until reloaded. Reload 🗙